{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:52:37Z","timestamp":1791730357034,"version":"4.3.4"},"reference-count":33,"publisher":"Informa UK Limited","issue":"19","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2018,8,31]]},"DOI":"10.2217\/fon-2017-0722","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T15:35:46Z","timestamp":1531928146000},"page":"1965-1976","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["The Next Generation of Therapy for Multiple Myeloma: A Review of Ongoing Clinical Trials Utilizing Clinicaltrials.gov"],"prefix":"10.1080","volume":"14","author":[{"given":"Peter","family":"Barth","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Warren Alpert Medical School of Brown University, Providence, RI02903, USA"},{"name":"Division of Hematology\/Oncology, Lifespan Cancer Institute, Providence, RI02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Vale","sequence":"additional","affiliation":[{"name":"Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison B","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI02903, USA"},{"name":"Lifespan Biostastistics Core, Lifespan Hospital System, Providence, RI02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Reagan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Warren Alpert Medical School of Brown University, Providence, RI02903, USA"},{"name":"Division of Hematology\/Oncology, Lifespan Cancer Institute, Providence, RI02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387"},{"key":"e_1_3_2_4_1","unstructured":"Howlader N NooneA KrapchoMet al. SEER cancer statistics review 1975\u20132014. National Cancer Institute Bethesda MD USA (2017). https:\/\/seer.cancer.gov\/csr\/1975_2014\/."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4177"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116129"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.23"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022340"},{"key":"e_1_3_2_11_1","unstructured":"FDA. Hematology\/oncology (Cancer) approvals & safety notifications (2017). www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm279174.htm."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411321"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01120-4"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505654"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70440-1"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.505.505"},{"key":"e_1_3_2_18_1","unstructured":"US FDA\n. FDA alerts healthcare professionals and oncology clinical investigators about two clinical trials on hold evaluating KEYTRUDA \u00ae (pembrolizumab) in patients with multiple myeloma. (2017). www.fda.gov\/Drugs\/DrugSafety\/ucm574305.htm."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-422683"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607751"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.3160"},{"key":"e_1_3_2_23_1","unstructured":"ClinicalTrials.gov\n. History policies and laws (2017). https:\/\/clinicaltrials.gov\/ct2\/about-site\/history."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.045"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2015.05.003"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318287c562"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181e76159"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2014.08.005"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1147.1147"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.03.018"},{"key":"e_1_3_2_31_1","article-title":"A multicenter open label Phase II study of pomalidomide, cyclophosphamide and dexamethasone in relpase multiple myeloma patients initially treated with lenalidomide, bortezomib and dexamethasone","author":"Garderet L","year":"2017","unstructured":"Garderet L , KuhnowskiF, MaryJet al. A multicenter open label Phase II study of pomalidomide, cyclophosphamide and dexamethasone in relpase multiple myeloma patients initially treated with lenalidomide, bortezomib and dexamethasone. American Society of Hematology, 59th Annual Meeting & Exposition, GA, USA (2017).","journal-title":"American Society of Hematology, 59th Annual Meeting & Exposition, GA, USA"},{"issue":"11","key":"e_1_3_2_32_1","first-page":"1","article-title":"Detection and characterization of circulating tumour cells in multiple myeloma","volume":"5","author":"Zhang L","year":"2016","unstructured":"Zhang L , BeasleyS, PrigozhinaNet al. Detection and characterization of circulating tumour cells in multiple myeloma. J. Circ. Biomark.5(11), 1\u20138 (2016).","journal-title":"J. Circ. Biomark."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.04.022"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.487.487"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2017-0722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:06Z","timestamp":1719125106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2017-0722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":33,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,8,31]]}},"alternative-id":["10.2217\/fon-2017-0722"],"URL":"https:\/\/doi.org\/10.2217\/fon-2017-0722","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}